Total Payments
$26,914
2024 Payments
$2,956
Companies
49
Transactions
1,215
Medicare Patients
1,672
Medicare Billing
$394,797
Payment Breakdown by Category
Food & Beverage$19,413 (72.1%)
Consulting$5,850 (21.7%)
Travel$1,534 (5.7%)
Education$116.88 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,413 | 1,200 | 72.1% |
| Consulting Fee | $5,850 | 2 | 21.7% |
| Travel and Lodging | $1,534 | 9 | 5.7% |
| Education | $116.88 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $10,128 | 140 | $0 (2024) |
| Amgen Inc. | $3,906 | 276 | $0 (2024) |
| PFIZER INC. | $1,502 | 127 | $0 (2024) |
| Janssen Biotech, Inc. | $1,487 | 95 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,116 | 62 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,100 | 56 | $0 (2024) |
| Genentech USA, Inc. | $1,042 | 57 | $0 (2024) |
| ABBVIE INC. | $818.99 | 41 | $0 (2024) |
| UCB, Inc. | $803.09 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $675.19 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,956 | 136 | GENZYME CORPORATION ($441.16) |
| 2023 | $2,487 | 127 | Amgen Inc. ($603.37) |
| 2022 | $1,923 | 108 | Amgen Inc. ($461.48) |
| 2021 | $1,131 | 68 | Amgen Inc. ($303.78) |
| 2020 | $1,408 | 93 | Amgen Inc. ($547.80) |
| 2019 | $3,591 | 253 | Amgen Inc. ($702.26) |
| 2018 | $7,420 | 230 | Lilly USA, LLC ($4,857) |
| 2017 | $5,997 | 200 | Lilly USA, LLC ($3,897) |
All Payment Transactions
1,215 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Inflammation | ||||||
| 11/28/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/15/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $149.09 | General |
| Category: Rheumatology | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $128.14 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/13/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $9.77 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Dermatology | ||||||
| 11/08/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Bone Health | ||||||
| 10/30/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $43.31 | General |
| Category: Immunology | ||||||
| 10/28/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/25/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 327 | 1,075 | $140,109 | $52,293 |
| 2022 | 11 | 445 | 1,108 | $143,629 | $58,332 |
| 2021 | 12 | 450 | 1,082 | $150,591 | $63,096 |
| 2020 | 11 | 450 | 11,519 | $602,111 | $221,076 |
Total Patients
1,672
Total Services
14,784
Medicare Billing
$394,797
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 363 | $76,956 | $31,260 | 40.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 37 | 122 | $34,770 | $11,639 | 33.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $9,246 | $3,265 | 35.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 17 | 65 | $8,840 | $2,936 | 33.2% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 56 | $3,696 | $1,173 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 25 | $3,600 | $1,139 | 31.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 67 | $2,144 | $674.48 | 31.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 149 | $447.00 | $109.59 | 24.5% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 47 | 205 | $410.00 | $97.69 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 344 | $72,928 | $30,559 | 41.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 36 | 112 | $31,920 | $11,678 | 36.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 43 | 43 | $17,286 | $6,510 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 60 | $8,640 | $3,582 | 41.5% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 20 | 51 | $6,936 | $2,632 | 37.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 19 | 19 | $1,710 | $1,302 | 76.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 37 | 59 | $1,888 | $624.48 | 33.1% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 16 | 16 | $720.00 | $593.44 | 82.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 21 | 21 | $630.00 | $588.84 | 93.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 26 | 205 | $615.00 | $171.20 | 27.8% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 40 | 178 | $356.00 | $90.75 | 25.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 153 | 397 | $84,164 | $35,436 | 42.1% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 39 | 136 | $38,760 | $14,984 | 38.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 33 | 33 | $13,266 | $5,272 | 39.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 52 | $7,488 | $3,059 | 40.9% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 37 | 37 | $1,665 | $1,412 | 84.8% |
About Dr. Stacy Kennedy, M.D
Dr. Stacy Kennedy, M.D is a Internal Medicine healthcare provider based in Salisbury, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063556496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stacy Kennedy, M.D has received a total of $26,914 in payments from pharmaceutical and medical device companies, with $2,956 received in 2024. These payments were reported across 1,215 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($19,413).
As a Medicare-enrolled provider, Kennedy has provided services to 1,672 Medicare beneficiaries, totaling 14,784 services with total Medicare billing of $394,797. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Salisbury, NC
- Active Since 02/18/2007
- Last Updated 03/18/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1063556496
Products in Payments
- Enbrel (Biological) $2,663
- TALTZ (Drug) $1,427
- XELJANZ (Drug) $1,089
- BENLYSTA (Biological) $1,022
- Cimzia (Drug) $779.83
- KEVZARA (Biological) $665.66
- SAPHNELO (Biological) $656.54
- Rituxan (Biological) $638.90
- TREMFYA (Drug) $619.23
- COSENTYX (Biological) $612.33
- SIMPONI ARIA (Biological) $594.81
- EVENITY (Biological) $514.09
- KRYSTEXXA (Biological) $484.23
- ACTHAR (Biological) $466.17
- ORENCIA (Biological) $461.08
- Humira (Biological) $371.13
- COSENTYX (Drug) $364.84
- Prolia (Biological) $329.74
- Rasuvo (Drug) $299.79
- RAYOS (Drug) $268.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Salisbury
Akhil Parashar, M.d, M.D
Internal Medicine — Payments: $48,967
Internal Medicine $48,967
Dr. Robert Mcneill, M.d, M.D
Internal Medicine — Payments: $14,247
Internal Medicine $14,247
Karim Arnaout, M.d, M.D
Internal Medicine — Payments: $8,657
Internal Medicine $8,657
Dr. David Bearss, M.d, M.D
Internal Medicine — Payments: $7,098
Internal Medicine $7,098
Dr. Justin Kucinski, Do, DO
Internal Medicine — Payments: $7,018
Internal Medicine $7,018
Dr. Nilesh Patel, M.d, M.D
Internal Medicine — Payments: $6,942
Internal Medicine $6,942